Iitri - pttp DRF BPN study - TO3
Ended Awarded Last action
- Contract number
- 75N95024F00002
- Awardee
-
IIT Research Institute UEI DGBUFQYMKWB5 Part of Illinois Institute Of Technology
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $438,148
Award facts
- Contract value 93% obligated
-
- $438,148.00 Current, with exercised options
- $473,586.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Chicago, IL 60616, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $218,025 | |
| Supplemental Agreement for work within scope | $55,756 | |
| Original award | $164,367 |
About this award
This is a $473,586.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS) to the IIT Research Institute (IITRI), a non-profit division of the Illinois Institute of Technology. The contract, which does not have a set-aside designation, is part of NINDS's Pharmacology and Toxicology for Therapeutics Program and supports preclinical research activities, including toxicology studies and safety assessments of potential treatments for neurological disorders. IITRI has extensive experience providing these types of preclinical services to federal agencies, including NINDS, through both prime contracts and subcontracts. The award is a task order under a larger $174.5 million single-award IDIQ contract between IITRI and NINDS, which enables the agency to efficiently access IITRI's comprehensive preclinical research capabilities on an as-needed basis.
Quick answers
Who was awarded contract 75N95024F00002?
75N95024F00002 was awarded to IIT Research Institute by National Institute on Drug Abuse (National Institutes of Health) on March 1, 2024.
How much is contract 75N95024F00002 worth?
The government has obligated $438,148 on 75N95024F00002. Its potential value, with all options, is $473,586.
Which agency awarded contract 75N95024F00002?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95024F00002, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Is contract 75N95024F00002 an order under another contract?
Yes. 75N95024F00002 is a delivery order under 75N95021D00026, an indefinite delivery contract.
Was contract 75N95024F00002 competed?
The extent of competition for 75N95024F00002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award